$IVZ

Invesco Ltd. Q2 2026: Revenue $1.83B, EPS $0.76— 10-Q Summary

Invesco Ltd. (IVZ) reported Q2 2026 revenue of $1.83B, up from $1.52B a year earlier. Net income attributable to Invesco was $345.3M versus a year-ago loss, and diluted EPS rose to $0.76 from $(0.03). The company cited higher AUM, $45.1B net long-term inflows, and ending AUM of $2.47T.

Original reporting
Published Aug 4, 2026, 7:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Invesco Ltd. Q2 2026: Revenue $1.83B, EPS $0.76— 10-Q Summary — source image
Decision brief

The 30-second read

$IVZBullishMed
01

Why it matters

Traders can use the new quarterly earnings and flow metrics to reassess near-term fundamentals for IVZ, especially around ETF and long-term inflow momentum.

02

Market read

Fresh Q2 financials and record long-term inflows are the core actionable inputs for IVZ positioning after the filing.

03

What to watch

The summary highlights QQQ conversion and higher marketing spend, but does not quantify margin impact or provide forward guidance, which could limit how far the market extrapolates.

Relevance 7/10Novelty 7/10Timing: post-market today, based on Aug. 4, 2026 Q2 10-Q

Background

The article is a brief summary of Invesco’s Q2 2026 results from its SEC 10-Q filing.

Company-level read

Ticker impact

$IVZBullishMedium confidence
Context

Invesco reported Q2 2026 revenue of $1.83B, diluted EPS of $0.76, and record net long-term inflows of $45.1B.

Expected impact

Likely supportive for IVZ sentiment given YoY improvement in net income and EPS, and record long-term inflows.

Evidence & confidence

The article discloses multiple new Q2 datapoints (revenue, net income, EPS, inflows, ending AUM) from an SEC 10-Q, but it lacks guidance or consensus comparisons that would sharpen magnitude of repricing.

Market effects

Strong ETF and long-term inflow commentary can reinforce the broader asset-management narrative around ETF distribution and AUM momentum.

Mentions China joint venture inflows, suggesting continued regional contribution to flows.

AUM growth and ETF inflow strength can marginally affect sentiment toward global passive/ETF demand.

Counterpoint

Record inflows may not translate into durable fee revenue if mix shifts or marketing spend rises faster than net revenue.

Key entities

  • Invesco Ltd.

    Asset manager reporting Q2 2026 revenue, EPS, net income, inflows, and ending AUM in an SEC 10-Q summary.

  • CI GAM

    Partner named in a strategic sub-advisory partnership established as part of Invesco’s business highlights.

Related articles

$IVZMed

Invesco Ltd. Q2 2026 Earnings Call Summary

Invesco reported Q2 2026 record net long-term inflows of $45.1B and operating margin of 37.5%, citing 17% year-to-date net revenue growth. Management said 30+ products drove over $500M in net inflows, with QQQ contributing $130M incremental net revenue in H1. It targets high-30s operating margin, a 60% payout ratio, and notes $15M quarterly one-time platform costs.

$IVZMed

Invesco (NYSE:IVZ) Surprises With Strong Q2 CY2026

Invesco (NYSE:IVZ) reported Q2 CY2026 results that beat expectations. Revenue rose 65.3% year over year to $1.83 billion, exceeding Wall Street estimates by 37%. Non-GAAP EPS was $0.71, 7.2% above consensus. Assets under management were $2.47 trillion, up 23.4% year over year, and the stock was about $30.37 after the release.

$IVZMedAI 8/10

Invesco Ltd. (IVZ): Results of Operations and Financial Condition

Invesco Ltd. (IVZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ivzpressrelease2q2026.htm EX-99.1 Document Exhibit 99.1 Press Release For immediate release Invesco Reports Results for the Three Months Ended June 30, 2026 Invesco Announces Second Quarter Diluted EPS of $0.76; Adjusted Diluted EPS (1) of $0.71 Investor Relations Conta